STAT+: Novartis gets multiple sclerosis win with BTK inhibitor

The story
More Trump drug pricing deals, GSK speeds up development of mRNA flu vaccine, and other biotech news
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events